
UnitedHealth Group Incorporated
UNHNYSEHealthcareMedical - Healthcare Plans
Previous close
$390.11
+$5.26 · +1.37%
UNH company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
46
Fair Value
Momentum
65
Gaining
Sentiment
71
Bullish
Risk resilience
84
Low Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteUnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
- Industry
- Medical - Healthcare Plans
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Stephen J. Hemsley
- Listed since
- Oct 17, 1984
- Employees
- 390,000
Market position
Day range
Current $390.11
52-week range
Current $390.11
- Open
- $385.06
- Previous close
- $384.85
- Volume
- 4.88M
- 0.75× average
- Average volume
- 6.5M
- Average daily volume
- Market cap
- 354.28B USD
- Beta
- 0.63
- Market reference 1
- 50-day average
- $413.79
- -5.72% below average
- 200-day average
- $347.99
- +12.10% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 354.42B USD
- EV / EBITDA
- 15.37×
- Earnings yield
- 4.01%
- Free cash flow yield
- 5.35%
Profitability & efficiency
- Return on equity
- 12.81%
- Return on assets
- 3.89%
- Return on invested capital
- 8.23%
Financial health
- Current ratio
- 0.79×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 447.57B USD | 400.28B USD | 371.62B USD | 324.16B USD | 287.6B USD |
| Cost of goods sold | 364.65B USD | 310.88B USD | 280.66B USD | 244.55B USD | 217.95B USD |
| Gross profit | 82.92B USD | 89.4B USD | 90.96B USD | 79.62B USD | 69.65B USD |
| Operating expenses | 63.95B USD | 57.11B USD | 58.6B USD | 51.18B USD | 45.68B USD |
| Interest expense | 4B USD | 3.91B USD | 3.25B USD | 2.09B USD | 1.66B USD |
| Depreciation and amortization | 4.36B USD | 4.1B USD | 3.97B USD | 3.4B USD | 3.1B USD |
| Operating income | 18.96B USD | 32.29B USD | 32.36B USD | 28.44B USD | 23.97B USD |
| Net income | 12.06B USD | 14.41B USD | 22.38B USD | 20.12B USD | 17.29B USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 82%
- 9 beats, 2 misses, 0 met estimates
- Average EPS surprise
- +4.48%
- 11 comparable reports
- Latest EPS result
- 6.38
- Estimate 4.94 · Beat by 29.15%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Analyst price target
Average target
$473.89
21.48% upsideCorporate actions
Annual dividends per share
Cash distributions grouped by calendar year; partial years are marked.
$8.73
2025 complete year+55.9% since 2021
2026 partial: $4.53
$5.60
2,021
$6.40
2,022
$7.29
2,023
$8.18
2,024
$8.73
2,025
$4.53
2,026*
* Partial calendar year in the available dividend history.
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Sep 14, 2026 | $2.32Quarterly | Sep 14, 2026 | Sep 22, 2026 |
Dividend | Jun 15, 2026 | $2.32Quarterly | Jun 15, 2026 | Jun 23, 2026 |
Dividend | Mar 9, 2026 | $2.21Quarterly | Mar 9, 2026 | Mar 17, 2026 |
Dividend | Dec 8, 2025 | $2.21Quarterly | Dec 8, 2025 | Dec 16, 2025 |
Dividend | Sep 15, 2025 | $2.21Quarterly | Sep 15, 2025 | Sep 23, 2025 |
Dividend | Jun 16, 2025 | $2.21Quarterly | Jun 16, 2025 | Jun 24, 2025 |
Ex-dividend Sep 14, 2026
$2.32
Quarterly
Record Sep 14, 2026 · Payment Sep 22, 2026
Ex-dividend Jun 15, 2026
$2.32
Quarterly
Record Jun 15, 2026 · Payment Jun 23, 2026
Ex-dividend Mar 9, 2026
$2.21
Quarterly
Record Mar 9, 2026 · Payment Mar 17, 2026
Ex-dividend Dec 8, 2025
$2.21
Quarterly
Record Dec 8, 2025 · Payment Dec 16, 2025
Ex-dividend Sep 15, 2025
$2.21
Quarterly
Record Sep 15, 2025 · Payment Sep 23, 2025
Ex-dividend Jun 16, 2025
$2.21
Quarterly
Record Jun 16, 2025 · Payment Jun 24, 2025
UNH peers
ETFs holding UNH
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI11.98B0.52%2.3T USD0.03%$378.24+0.44%
Vanguard S&P 500 ETFVOO9.88B0.58%1.7T USD0.03%$703.71+0.39%
iShares Core S&P 500 ETFIVV4.71B0.53%891.84B USD0.03%$769.31+0.39%
State Street SPDR S&P 500 ETFSPY4.34B0.53%817.87B USD0.09%$765.72+0.41%
Schwab U.S. Dividend Equity ETFSCHD4.24B3.78%112B USD0.06%$35.11+0.80%
Vanguard Morningstar Value ETFVTV3.58B1.39%256.5B USD0.03%$226.4+0.54%
State Street Health Care Select Sector SPDR ETFXLV2.51B5.62%44.76B USD0.08%$174.62+1.29%
Vanguard Dividend Appreciation ETFVIG2.13B1.62%130.9B USD0.04%$243.91+0.69%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 11.98B
- Weight
- 0.52%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard S&P 500 ETFVOO- Market value
- 9.88B
- Weight
- 0.58%
- AUM
- 1.7T USD
- Expense ratio
- 0.03%
- Price / 1D
- $703.71+0.39%
iShares Core S&P 500 ETFIVV- Market value
- 4.71B
- Weight
- 0.53%
- AUM
- 891.84B USD
- Expense ratio
- 0.03%
- Price / 1D
- $769.31+0.39%
State Street SPDR S&P 500 ETFSPY- Market value
- 4.34B
- Weight
- 0.53%
- AUM
- 817.87B USD
- Expense ratio
- 0.09%
- Price / 1D
- $765.72+0.41%
Schwab U.S. Dividend Equity ETFSCHD- Market value
- 4.24B
- Weight
- 3.78%
- AUM
- 112B USD
- Expense ratio
- 0.06%
- Price / 1D
- $35.11+0.80%
Vanguard Morningstar Value ETFVTV- Market value
- 3.58B
- Weight
- 1.39%
- AUM
- 256.5B USD
- Expense ratio
- 0.03%
- Price / 1D
- $226.4+0.54%
State Street Health Care Select Sector SPDR ETFXLV- Market value
- 2.51B
- Weight
- 5.62%
- AUM
- 44.76B USD
- Expense ratio
- 0.08%
- Price / 1D
- $174.62+1.29%
Vanguard Dividend Appreciation ETFVIG- Market value
- 2.13B
- Weight
- 1.62%
- AUM
- 130.9B USD
- Expense ratio
- 0.04%
- Price / 1D
- $243.91+0.69%
Continue in GoAI
Research UNHresearch.disclaimer





